Cutler Group’s Cellectis CLLS Stock Holding History

Cutler Group’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,500	Closed	-$2K	–	4529
2017 Q4	$2K	Buy	+1,500	New	+$40.9K	﹤0.01%	4105
2017 Q1	–	Sell	-200	Closed	-$2K	–	6445
2016 Q4	$2K	Sell	200 -5,000	-96%	-$92.4K	﹤0.01%	5562
2016 Q3	$14K	Buy	+5,200	New	+$136K	﹤0.01%	3787

Other funds holding CLLS

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Cutler Group's CLLS Position: Q1 2024 in Review

Cutler Group sold out of Cellectis (CLLS) in Q1 2024, closing a stake of 200 shares.

Cutler Group first reported a position in CLLS in Q3 2016 and held it in 8 quarters. The position peaked at $46K in Q4 2017. 31 funds tracked by Wall St. Rank hold CLLS as of Q1 2024.

Cutler Group reported no remaining Cellectis position as of Q1 2024 after selling out during the quarter.
Cutler Group sold 200 Cellectis shares in Q1 2024.
Cutler Group first reported a position in Cellectis in Q3 2016 and held it in 8 quarters.
Cutler Group's Cellectis position peaked at $46K in Q4 2017.
31 funds tracked by Wall St. Rank held Cellectis as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.